Synergistic Strategies: ADC-PARP Inhibitor Combinations in Triple-Negative Breast Cancer Therapy DOI

Mokhtar Rejili

Pathology - Research and Practice, Год журнала: 2025, Номер 272, С. 156075 - 156075

Опубликована: Июнь 4, 2025

Язык: Английский

Cerebrolysin in post-TBI recovery: Pharmacology and clinical evidence DOI
Doha El‐Sayed Ellakwa,

Ahmed Mansour,

Rimon Gorgui

и другие.

Gene Reports, Год журнала: 2025, Номер unknown, С. 102202 - 102202

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

1

Metabolomics as a tool for understanding and treating triple-negative breast cancer DOI
Gyas Khan, Md Sadique Hussain, Sarfaraz Ahmad

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Май 2, 2025

Язык: Английский

Процитировано

1

PARP1-PROTACs Providing Novel Opportunities in Precision Oncology by Targeting DNA Damage Response DOI
Md Sadique Hussain, Gaurav Gupta

DNA repair, Год журнала: 2025, Номер 150, С. 103851 - 103851

Опубликована: Май 21, 2025

Язык: Английский

Процитировано

0

Hyaluronic Acid Conjugated Geraniol for Targeted Breast Cancer Therapy DOI Creative Commons

Han Yu,

Lingling Jiang,

Yindu Bai

и другие.

Natural Product Communications, Год журнала: 2025, Номер 20(5)

Опубликована: Май 1, 2025

Objectives: Geraniol, a natural compound found in various essential oils and plant extracts, has shown promising anti-cancer effects on multiple types of cancer. This study aimed to examine the properties hyaluronic acid (HA)-conjugated geraniol (HA-geraniol) specifically breast cancer cells. Methods: investigated HA-geraniol both murine 4T1 human MDA-MB-231 cell lines. Mitochondrial membrane potential loss, apoptosis-inducing ability, cycle arrest were evaluated using flow cytometry. Additionally, tandem mass tag (TMT)-based proteomics analysis was conducted identify differentially expressed proteins cells following treatment with HA-geraniol. An vivo efficacy carried out 4T1-bearing BALB/c mouse xenograft model assess therapeutic impact compared naked drug. Results: The vitro experiments demonstrated that exhibited superior It induce mitochondrial apoptosis, Proteomic revealed may mediate death by up-regulating ATF3 activating complement coagulation cascade pathways. Furthermore, indicated effectively suppressed tumor growth metastasis model, showcasing its as agent for therapy. Conclusion: findings from this suggest holds great promise an efficient therapy, demonstrating significant .

Язык: Английский

Процитировано

0

Synergistic Strategies: ADC-PARP Inhibitor Combinations in Triple-Negative Breast Cancer Therapy DOI

Mokhtar Rejili

Pathology - Research and Practice, Год журнала: 2025, Номер 272, С. 156075 - 156075

Опубликована: Июнь 4, 2025

Язык: Английский

Процитировано

0